Home › Cystic Fibrosis › California › San Francisco
Cystic Fibrosis clinical trials in San Francisco, CA
4 studies for Cystic Fibrosis are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis
RecruitingPhase 2
- University of California, San Francisco, San Francisco
4D-710 in Adult Patients With Cystic Fibrosis
RecruitingPhase 2
- University of California San Francisco, San Francisco
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
RecruitingObservational study
- University of California, San Francisco - Adult Center, San Francisco
- University of California, San Francisco - Peds Center, San Francisco
Study With Phage for CF Subjects With Pseudomonas Lung Infection
RecruitingPhase 2
- University of California San Francisco, San Francisco
About Cystic Fibrosis
Cystic fibrosis (CF) is an inherited disease of the mucus and sweat glands. The symptoms and severity of CF can vary. Get the facts.
More about Cystic Fibrosis on MedlinePlus
Cystic Fibrosis trials in other cities
- Boston, MA16 studies
- Philadelphia, PA16 studies
- Birmingham, AL15 studies
- Kansas City, KS13 studies
- Seattle, WA13 studies
- Pittsburgh, PA11 studies
- Baltimore, MD11 studies
- Denver, CO11 studies
- Dallas, TX11 studies
- Cincinnati, OH10 studies
- Los Angeles, CA9 studies
- Minneapolis, MN9 studies
Other studies in San Francisco
- Prostate Cancer44 studies
- Breast Cancer40 studies
- Cancer (all types)38 studies
- Non-Small Cell Lung Cancer37 studies
- Heart Failure29 studies
- Metastatic Cancer25 studies
- Lung Cancer23 studies
- Melanoma21 studies
- Ovarian Cancer20 studies
- Cardiovascular Disease20 studies
- Pancreatic Cancer19 studies
- Glioblastoma19 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.